When a regulatory authority sends four auditors to examine every system, every batch record, and every quality decision your organization has made — the results don’t lie.
Our most recent FDA inspection spanned six days. Four auditors. Every system reviewed. The outcome: zero observations.
This is not a headline we share lightly. In biologics manufacturing, FDA inspections represent the highest standard of operational scrutiny. Achieving zero findings is a direct reflection of the quality culture we have built and maintained over four decades — and it carries significant implications for every partner who trusts us with their pipeline.
Bring Your Product to Market with a Partner You Can Trust
Achieving FDA approval for a biologic is one of the most complex, high-stakes endeavours in the pharma and biotech industries. The manufacturing partner you choose should strengthen your ability to get there on time, on specification, and with full compliance.
Our operational discipline speaks for itself — validated, once again, by the results of our most recent FDA inspection.
Discover our operational discipline and learn how we can support your path from development to market with the quality standards your product demands.
Ready to discuss your manufacturing timeline? Contact our team for a custom quote.